Verona Pharma plc

Ownership Transactions Reported by 19 Insiders

Symbol
VRNA on Nasdaq
Location
3 More London Riverside, London, United Kingdom

Insiders trading volume in the past year

Verona Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Zaccardelli President and CEO, Director $1.29B -$22.9M -1.75% Aug 29, 2025
Mark Hahn Chief Financial Officer $1.19B -$22.9M -1.89% Aug 29, 2025
Kathleen A. Rickard Chief Medical Officer $255M -$3.6M -1.39% Aug 29, 2025
Access Industries Holdings LLC 10%+ Owner $110M Aug 15, 2022
David R. Ebsworth Director $101M +$278K +0.28% Aug 1, 2025
Andrew Fisher General Counsel $28.2M -$1.16M -3.93% Aug 1, 2025
Anders Ullman Director $24.2M Aug 1, 2025
Martin Edwards Director $10.7M Aug 1, 2025
Orbimed Advisors Llc Director $7.46M May 11, 2023
Rishi Gupta Director $7.46M May 11, 2023
Vikas Sinha Director $6.36M -$2.93M -31.5% Aug 1, 2025
Mahendra Shah Director $6.32M Aug 1, 2025
Lisa Deschamps Director $5.73M Aug 1, 2025
Claire Poll General Counsel $5.53M Feb 1, 2024
Kenneth Cunningham Director $5.39M Aug 1, 2025
Christina Ackermann Director $4.33M -$139K -3.12% Aug 1, 2025
James Aloysius Brady Director $1.57M Aug 1, 2025
Michael Austwick Director $859K Aug 1, 2025
Andrew Sinclair Director Aug 9, 2021

Recent Insider Transactions by Companies or Individuals for Verona Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.